Purchase Order 75F40125P00211
Award Date
9/8/25
Potential Completion Date
2/21/26
Potential Value
$258K
Federal Agency
Food and Drug Administration
Awardee
Axion Biosystems, Inc.
Ultimate Awardee
Not listed
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
PSC Category
AJ12 - General Science And Technology R&D Services; General Science And Technology; Applied Research
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20993, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $140,204.00 firm-fixed-price purchase order contract awarded by the U.S. Department of Health and Human Services' Food and Drug Administration (FDA) to Axion Biosystems, Inc., a foreign-owned, for-profit manufacturer of goods. The contract is for the delivery of a Micro-Electrode Assay System, a specialized laboratory instrument used in biomedical research initiatives across agencies like the National Institutes of Health (NIH), EPA, and VA. As a small business set-aside, this award...
This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Axion Biosystems, Inc., a foreign-owned for-profit manufacturer of specialized laboratory equipment. The $218,346.00 contract is for the Maestro Multiwell System and related service agreement. Axion Biosystems provides the FDA with its proprietary Maestro multi-electrode array (MEA) systems, Maestro Apex automated incubators, and consumables to support the agency's biomedical research and drug...
This is a $23,690.00 firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Axion Biosystems, Inc., a foreign-owned, for-profit manufacturer of advanced laboratory equipment based in Atlanta, Georgia. The contract is for the procurement of laboratory supplies and consumables to support the FDA's Center for Drug Evaluation and Research (CDER). This award is a small business set-aside and is not associated with a larger contract vehicle. Axion Biosystems has a history...
This federal contract award is for the procurement of microelectrode array (MEA) lab equipment, including the Maestro multi-well MEA system, from Axion Biosystems, Inc. The $163,750.00 firm fixed-price purchase order was issued by the Department of Health and Human Services' Food and Drug Administration. The contract has a completion date of December 1, 2022 and includes two 1-year post-warranty maintenance option periods. Axion Biosystems is a life science company that develops technologies for...
This federal contract award, with ID HHSF223201510126A, was made by the Food and Drug Administration (FDA) to Axion Biosystems, Inc., a foreign-owned, for-profit manufacturer of specialized laboratory equipment and instruments. The $219,708.00 firm-fixed-price purchase order is for the acquisition of a high-throughput microelectrode assay system, plus 4 years of preventive maintenance services. The award does not have a set-aside designation. Axion Biosystems is a provider of live cell...
This is a $19,050.00 firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Axion Biosystems, Inc., a foreign-owned, for-profit manufacturer based in Atlanta, Georgia. The contract is for the delivery of E-STIM + MEA 48-WELL PLATES, which are specialized scientific instruments and laboratory equipment used in biomedical and drug development research. The contract was set aside for small businesses and has an ultimate completion date of September 13, 2018. Axion...
This is a $5,480 firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Axion Biosystems, Inc., a foreign-owned manufacturer based in Atlanta, Georgia. The contract is for the delivery of well plates and microelectrodes, which are specialized laboratory equipment used for real-time monitoring of neural and cardiac cellular activities. The contract was set aside for small businesses. Axion Biosystems has a strong track record of providing advanced live cell...
The Department of Health and Human Services Food and Drug Administration awarded a $317,900 firm fixed price purchase order to Axion Biosystems, Inc. for the delivery of one Axion Biosystem Maestro Multi-Well Microelectrode Array system. The system will meet the technical requirements outlined in the FDA's February 2023 special notice, including integrated signal amplification, digitization and stimulation hardware, environmental controls, automated plate docking, stimulus design capabilities,...
This federal contract award, with ID HHSF223201510728P, was made by the Food and Drug Administration (FDA) to Axion Biosystems, Inc., a foreign-owned, for-profit manufacturer of advanced live cell analysis technologies and laboratory equipment. The $135,232.00 firm fixed-price purchase order is for the AXION MAESTRO 768D MULTI ELECTRODE RSVP 1043 system, which is likely used in biomedical and drug development research. Axion Biosystems has received numerous prior federal contract awards,...
This is a $242,600 firm fixed-price purchase order contract awarded by the Department of Health and Human Services Food and Drug Administration to Axion Biosystems, Inc. for the provision of the Maestro/Microelectrode Array System. The contract supports biomedical research initiatives across federal agencies including the NIH, FDA, EPA, and VA, providing specialized laboratory equipment, instruments, consumables, and related services such as installation, training, maintenance, and repair. The...